Frank Namdar - 21 Feb 2023 Form 4 Insider Report for UMPQUA HOLDINGS CORP

Signature
/s/ Andrew H. Ognall, Attorney-in-Fact for Frank Namdar
Issuer symbol
N/A
Transactions as of
21 Feb 2023
Net transactions value
$0
Form type
4
Filing time
23 Feb 2023, 10:46:01 UTC
Previous filing
09 Mar 2022
Next filing
02 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UMPQ Common Stock Other $0 +537 +14% $0.000000 4,368 21 Feb 2023 by 401(k) F1, F2
transaction UMPQ Common Stock Other $0 +1,060 +36% $0.000000 4,003 21 Feb 2023 by SRP Plan F2, F3
transaction UMPQ Common Stock Award $0 +12,145 +31% $0.000000 51,041 21 Feb 2023 Direct F2, F4
transaction UMPQ Common Stock Award $0 +6,072 +12% $0.000000 57,113 21 Feb 2023 Direct F2, F5
transaction UMPQ Common Stock Award $0 +6,072 +11% $0.000000 63,185 21 Feb 2023 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings reported include shares acquired in the 401(k)/Profit Sharing plan through dividend reinvestment, payroll deferrals and/or employer contributions in transactions that were exempt under Rule 16b-3(c).
F2 Not required.
F3 Holdings reported include shares acquired in the issuer's Nonqualified Deferred Compensation Plan through dividend reinvestment, payroll deferrals and/or employer contributions in transactions that were exempt under Rule 16b-3(c).
F4 Restricted stock unit award granted 2/21/23. The award vests 34% on February 15, 2024, and 33% on February 15, 2025, and 2026.
F5 Performance share award granted 2/21/23. The award vests in the first quarter of 2026 based on the issuer's relative total shareholder return from January 1, 2023 through December 31, 2025 compared to a Compensation Committee approved group of peers.
F6 Performance share award granted 2/21/23. The award vests in the first quarter of 2026 based on the issuer's relative return on tangible common equity for fiscal years 2023-2025 compared to a Compensation Committee approved group of peers.